Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT00949884
Olmesartan Comparison to Losartan in Hypertensive Subjects
941
Enrollment(s)
0
Study location(s)
Interventional (Phase IV)
Hypertension
Unknown status
NCT00599625
Pravastatin Therapy in Patients With Active Crohn's Disease: A Pilot Study
40
Enrollment(s)
1
Study location(s)
Interventional (Not Applicable)
Crohn's Disease
Completed
NCT00971399
Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting
172
Enrollment(s)
1
Study location(s)
Interventional (Phase III)
Radiotherapy Induced Nausea and Vomiting
Completed
NCT00311155
Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension
694
Enrollment(s)
40
Study location(s)
Interventional (Phase IV)
Essential Hypertension
Completed
NCT00214604
Type III Dysbetalipoproteinemia
30
Enrollment(s)
2
Study location(s)
Interventional (Phase III)
Hyperlipoproteinemia Type III
Completed
NCT01155765
Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis
70
Enrollment(s)
1
Study location(s)
Interventional (Phase III)
Hemodialysis
Chronic Renal Failure
Completed
NCT00356135
Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event
139
Enrollment(s)
9
Study location(s)
Interventional (Phase II)
Coronary Arteriosclerosis
Acute Coronary Syndrome
Completed
NCT00151827
Olmesartan Medoxomil in Hypertension and Renal Impairment
393
Enrollment(s)
0
Study location(s)
Interventional (Phase III)
Essential Hypertension
Renal Impairment
96
97
98
99
100